TY - JOUR
T1 - A new diagnostic test to assess airway reactivity in asthmatics
AU - Kivity, S.
AU - Souhrada, J. F.
PY - 1981
Y1 - 1981
N2 - A new, simple test to assess reactivity using a voluntary isocapnic hyperpnea (VIH) is described. The test consists of baseline determinations of pulmonary function, followed by 5 min of voluntary isocapnic hyperventilation of a CO2-room air mixture (20-22°C and relative humidity of 7-15%) at ventilatory levels between 25-45 L/min-1. Then pulmonary function tests are repeated. Utilizing this test it was found that, in asthmatics (n = 11), a dose-response-like relationship exists between voluntary isocapnic hyperpnea (VIH) and the bronchoconstrictive response, as measured by pulmonary function tests. Furthermore, it was observed that this response shows relatively good reproducibility. For comparison, airway response to the standardized methacholine inhalation challenge was also examined in normals and asthmatics. The response was evaluated by both PD35 (for SGaw) and the slope of the dose-response relationship. PD35 was defined as the level of ventilation or concentration of methacholine, at which a decrease of 35% in specific airway conductance (SGaw) was observed. Our study revealed that the VIH challenge is more specific in the detection of airway hyperreactivity than the methacholine inhalation challenge. Five normal subjects demonstrated no measurable airway response to VIH but did respond to the methacholine inhalation challenge.
AB - A new, simple test to assess reactivity using a voluntary isocapnic hyperpnea (VIH) is described. The test consists of baseline determinations of pulmonary function, followed by 5 min of voluntary isocapnic hyperventilation of a CO2-room air mixture (20-22°C and relative humidity of 7-15%) at ventilatory levels between 25-45 L/min-1. Then pulmonary function tests are repeated. Utilizing this test it was found that, in asthmatics (n = 11), a dose-response-like relationship exists between voluntary isocapnic hyperpnea (VIH) and the bronchoconstrictive response, as measured by pulmonary function tests. Furthermore, it was observed that this response shows relatively good reproducibility. For comparison, airway response to the standardized methacholine inhalation challenge was also examined in normals and asthmatics. The response was evaluated by both PD35 (for SGaw) and the slope of the dose-response relationship. PD35 was defined as the level of ventilation or concentration of methacholine, at which a decrease of 35% in specific airway conductance (SGaw) was observed. Our study revealed that the VIH challenge is more specific in the detection of airway hyperreactivity than the methacholine inhalation challenge. Five normal subjects demonstrated no measurable airway response to VIH but did respond to the methacholine inhalation challenge.
UR - http://www.scopus.com/inward/record.url?scp=0019445971&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 7025936
AN - SCOPUS:0019445971
SN - 0272-7587
VL - 17
SP - 243
EP - 254
JO - Clinical Respiratory Physiology
JF - Clinical Respiratory Physiology
IS - 2
ER -